Showing results (261-270 of 6,497) with videos related to

Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|February 4, 2026
Impact of intralesional tuberculin PPD injection on anogenital warts: Interferon-α, interleukin-2, and treatment outcomesPati Aji Achdiat, Oki Suwarsa, Yudi Mulyana Hidayat, et al.
Human Vaccines & Immunotherapeutics|January 21, 2026
Human papillomavirus vaccinations' association to childbirth ratesTiina Koivisto, Tiina Eriksson, Mari Hokkanen, et al.
Human Vaccines & Immunotherapeutics|January 19, 2026
Awareness of the link between HPV and cancer according to cancer type and gender in the US from 2014-2020Joël Fokom Domgue, Nada Al-Antary, Mary A Gerend, et al.
Human Vaccines & Immunotherapeutics|January 27, 2026
Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccinationKathleen Kim, Carolina Porras, Aimee R Kreimer, et al.
Human Vaccines & Immunotherapeutics|March 26, 2025
Fundamental knowledge and research regarding the role of immunity in triple-negative breast cancer from 2014-2024: A bibliometric analysisXudong Li, Chun Lou, He Ren, et al.
Human Vaccines & Immunotherapeutics|March 24, 2025
Demographics and clinical burden of disease among RSV-hospitalized older adults in Italy: A retrospective cohort studyAnna Puggina, Melania Dovizio, Alexander Domnich, et al.
Human Vaccines & Immunotherapeutics|March 25, 2025
Overcoming barriers to medical countermeasures: Strengthening global biosecurityKaushal Sharma, Safia Syeda, Sanket M Shah, et al.
Human Vaccines & Immunotherapeutics|March 18, 2025
Seroprevalence of antibodies to hepatitis A, B and C viruses across all age groups in Chonburi Province, Thailand, 2022-2023Nasamon Wanlapakorn, Jira Chansaenroj, Preeyaporn Vichaiwattana, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Factors associated with HPV vaccination among adult women in QuebecMarilou Kiely, Chantal Sauvageau, Eve Dubé, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine: an open-label, randomized study in adults aged 18-60 years and olderPierre Van Damme, Froukje Kafeja, Vinod Bambure, et al.
Pageof 650